Dr Donald T Hudak, MD | |
374 Northside Dr, Batesville, IN 47006-7038 | |
(812) 496-8782 | |
(812) 539-1800 |
Full Name | Dr Donald T Hudak |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 27 Years |
Location | 374 Northside Dr, Batesville, Indiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396709234 | NPI | - | NPPES |
2424022 | Medicaid | OH | |
64064462 | Medicaid | KY | |
P00443351 | Other | OH | RR MEDICARE |
000000533203 | Other | ANTHEM BC/BS | |
1011062680001 | Medicaid | PA |
Facility Name | Location | Facility Type |
---|---|---|
Dearborn County Hospital | Lawrenceburg, IN | Hospital |
St Elizabeth Edgewood | Edgewood, KY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Summit Medical Group, Inc | 2163326240 | 693 |
Summit Medical Group, Inc | 2163326240 | 693 |
News Archive
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that data from a new study shows that Clarient's Ovotax™ assay may effectively predict which ovarian cancer patients will respond favorably to taxane therapy and could, therefore, be spared the potential side effects of this rigorous and sometimes toxic chemotherapy agent.
Teva Respiratory announced today that the U.S. Food and Drug Administration (FDA) has approved ProAir HFA with a dose counter for use in patients 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.
Electronic cigarettes could increase the number of people who stop smoking compared to nicotine replacement therapy – such as chewing gum and patches – according to research involving the University of East Anglia.
Altogen Labs, a biology contract research organization and provider of pre-clinical research services, announced its launch of a pyrosequencing service today.
› Verified 9 days ago
Entity Name | Summit Medical Group, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1881026169 PECOS PAC ID: 2163326240 Enrollment ID: O20031120000738 |
News Archive
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that data from a new study shows that Clarient's Ovotax™ assay may effectively predict which ovarian cancer patients will respond favorably to taxane therapy and could, therefore, be spared the potential side effects of this rigorous and sometimes toxic chemotherapy agent.
Teva Respiratory announced today that the U.S. Food and Drug Administration (FDA) has approved ProAir HFA with a dose counter for use in patients 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.
Electronic cigarettes could increase the number of people who stop smoking compared to nicotine replacement therapy – such as chewing gum and patches – according to research involving the University of East Anglia.
Altogen Labs, a biology contract research organization and provider of pre-clinical research services, announced its launch of a pyrosequencing service today.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Donald T Hudak, MD Po Box 635283, Cincinnati, OH 45263-5283 Ph: (812) 496-8782 | Dr Donald T Hudak, MD 374 Northside Dr, Batesville, IN 47006-7038 Ph: (812) 496-8782 |
News Archive
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that data from a new study shows that Clarient's Ovotax™ assay may effectively predict which ovarian cancer patients will respond favorably to taxane therapy and could, therefore, be spared the potential side effects of this rigorous and sometimes toxic chemotherapy agent.
Teva Respiratory announced today that the U.S. Food and Drug Administration (FDA) has approved ProAir HFA with a dose counter for use in patients 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.
Electronic cigarettes could increase the number of people who stop smoking compared to nicotine replacement therapy – such as chewing gum and patches – according to research involving the University of East Anglia.
Altogen Labs, a biology contract research organization and provider of pre-clinical research services, announced its launch of a pyrosequencing service today.
› Verified 9 days ago
Eric D Scripture, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1049 State Road 229, Batesville, IN 47006 Phone: 812-934-9500 Fax: 812-933-1771 | |
Dr. Ira Younger, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 374 Northside Dr, Batesville, IN 47006 Phone: 812-496-8782 Fax: 812-539-1800 | |
Dr. Gerald James Roper, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1049 State Road 229 N, Batesville, IN 47006 Phone: 812-934-9400 Fax: 812-933-0913 |